Advancing Vaccine Excellence

Published on 19 December 2024

Safer. Scalable. Sustainable.

InVitria is transforming vaccine production with safer, scalable, and sustainable solutions. This infographic showcases how our recombinant, animal-free technologies address key challenges in traditional vaccine manufacturing, such as contamination risks, inconsistent supply, and cold chain logistics.

Key highlights include:

• Safer Solutions: Eliminate risks from animal- and human-derived components, ensuring vaccine quality and patient safety.
• Scalable Manufacturing: Achieve higher yields and reliable production from research to industrial scale.
• Sustainable Practices: Produced using a plant-based expression system, our recombinant products reduce environmental impact, extend shelf-life, minimize waste, and support global vaccine accessibility.

By leveraging chemically defined, animal-free products like OptiVERO^®, Cellastim^® S and Exbumin^®, we enable consistent, high-quality vaccines while simplifying handling, logistics, and regulatory approval. This infographic provides a visual summary of our innovative approach to advancing global health.

Discover more about how InVitria accelerates vaccine innovation at https://invitria.com/application/vaccine-cell-culture-media/

Advancing_Vaccine_Excellence_infog